Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung
Clinical Lung Cancer · 2025-11 · 26 (7) · 583-594.e4
DOI: 10.1016/j.cllc.2025.06.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025-11. Verfasst von Katsuhiro Masago und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan; Division of Translational Oncoimmunology, Aichi Cancer…. Hauptthemen laut MEDLINE: Adenocarcinoma, Mucinous, Lung Neoplasms, Biomarkers, Tumor, Adenocarcinoma of Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Invasive mucinous adenocarcinoma (IMA) is a rare subtype of lung adenocarcinoma, accounting for 3%-10% of cases. It is often associated with KRAS mutations or, in nonsmokers, NRG1 fusions. Approximately 20% of IMAs have unclear genomic backgrounds. This study aimed to clarify the genomic etiology of these cases through a retrospective molecular analysis and RNA sequencing. PATIENTS AND METHODS: This study analyzed 107 cases of NSCLC that were treated by surgical resection at Aichi Cancer Center from 2009 to 2023, with a focus on IMAs. For cases with unclear genomic backgrounds, RNA sequencing was conducted to identify potential driver gene alterations, and the results were compared to those of known KRAS-positive cases. Statistical analyses, including Cox regression and Kaplan-Meier analyses, were used to evaluate risk factors, recurrence-free survival, and the prognosis. RESULTS: In this study, 107 cases of resected IMA were analyzed. KRAS mutations were found in 70.1% of cases, followed by NRG1 fusions (9.2%), and other mutations. A novel fusion gene, ATP6V1H::LYN, was discovered in 1 case. RNA sequencing and a gene set enrichment analysis revealed distinct molecular pathways in KRAS-positive tumors, including the activation of oxidative phosphorylation and TNFα-NF-κB signaling. Tumors with no driver gene alterations exhibited a higher frequency of copy number variations and tumor mutational burden than KRAS and NRG fusion-positive cases. CONCLUSION: IMAs are characterized by relatively higher incidences of harboring KRAS mutations and NRG fusion genes, revealing potential therapeutic targets including druggable mutations and immune-related markers, while highlighting the heterogeneous genomic background and utility of RNA sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Aichi, Japan. Electronic address: masago@a…
- Department of Thoracic Surgery, Teikyo University Mizonokuchi Hospital, Kanagawa, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Aichi, Japan.
- Department of Thoracic Surgery, Aichi Cancer Center Hospital, Aichi, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Aichi, Japan.
- Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Aichi, Japan.
- Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Aichi, Japan.
- Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Aichi, Japan.
Zitieren
APA
Masago, K., Kuroda, H., Seto, K., Sasaki, E., Fujita, Y., Horio, Y., Fujita, S., & Matsushita, H. (2025). Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung. Clinical Lung Cancer, 26(7), 583-594.e4. https://doi.org/10.1016/j.cllc.2025.06.004
Vancouver
Masago K, Kuroda H, Seto K, Sasaki E, Fujita Y, Horio Y, et al. Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung. Clinical Lung Cancer. 2025;26(7):583-594.e4. doi:10.1016/j.cllc.2025.06.004
BibTeX
@article{Masago2025,
author = {Masago, Katsuhiro and Kuroda, Hiroaki and Seto, Katsutoshi and Sasaki, Eiichi and Fujita, Yasuko and Horio, Yoshitsugu and Fujita, Shiro and Matsushita, Hirokazu},
title = {Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung},
journal = {Clinical Lung Cancer},
year = {2025},
volume = {26},
number = {7},
pages = {583--594.e4},
doi = {10.1016/j.cllc.2025.06.004}
}
EUVIMED